PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $0.56 per share as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2022-11-14
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.56.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.70.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.72.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $0.72.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2022-09-30 | $0.56 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.70 10-K · filed 2022-09-28 |
| 2022-03-31 | $0.72 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.72 10-Q · filed 2022-02-09 |
| 2021-09-30 | $0.72 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.67 10-K · filed 2021-09-27 |
| 2021-03-31 | $0.65 10-Q · filed 2021-05-14 |
| 2020-12-31 | $0.62 10-Q · filed 2021-02-09 |
| 2020-09-30 | $0.62 10-Q · filed 2020-11-13 |
| 2020-06-30 | $0.62 10-K · filed 2020-09-25 |
| 2020-03-31 | $0.65 10-Q · filed 2020-05-13 |
| 2019-12-31 | $0.64 10-Q · filed 2020-02-12 |
| 2019-09-30 | $0.64 10-Q · filed 2019-11-13 |
| 2019-06-30 | $0.64 10-K · filed 2019-09-27 |
| 2019-03-31 | $0.67 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.67 10-Q · filed 2019-02-13 |
| 2018-09-30 | $0.68 10-Q · filed 2018-11-09 |
| 2018-06-30 | $0.68 10-K · filed 2018-09-26 |
| 2018-03-31 | $0.76 10-Q · filed 2018-05-04 |
| 2017-12-31 | $0.76 10-Q · filed 2018-02-09 |
| 2017-09-30 | $0.76 10-Q · filed 2017-11-14 |
| 2017-06-30 | $0.78 10-K · filed 2017-09-28 |
| 2017-03-31 | $1.02 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.06 10-Q · filed 2017-02-09 |
| 2016-09-30 | $1.06 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.20 10-K · filed 2016-09-09 |
| 2016-03-31 | $1.48 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.90 10-Q · filed 2016-02-09 |
| 2015-09-30 | $1.94 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.93 10-K · filed 2015-09-14 |
| 2015-03-31 | $2.00 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.00 10-Q · filed 2015-02-17 |
| 2014-09-30 | $2.07 10-Q · filed 2014-11-14 |
| 2014-06-30 | $2.02 10-K · filed 2014-09-29 |
| 2014-03-31 | $1.86 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.84 10-Q · filed 2014-02-14 |
| 2013-09-30 | $1.84 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.87 10-K · filed 2013-09-30 |
| 2013-03-31 | $1.87 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.87 10-Q · filed 2013-02-14 |
| 2012-09-30 | $1.86 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.86 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |